BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/25/2024 8:51:43 AM | Browse: 258 | Download: 503
 |
Received |
|
2023-12-21 15:07 |
 |
Peer-Review Started |
|
2023-12-21 15:07 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-02-03 02:37 |
 |
Revised |
|
2024-02-17 04:09 |
 |
Second Decision |
|
2024-03-15 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-03-15 07:02 |
 |
Articles in Press |
|
2024-03-15 07:02 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-22 01:35 |
 |
Publish the Manuscript Online |
|
2024-04-25 05:24 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell Biology |
Manuscript Type |
Review |
Article Title |
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
|
Manuscript Source |
Invited Manuscript |
All Author List |
Xiang-Yi Hou, La-Mu Danzeng, Yi-Lin Wu, Qian-Hui Ma, Zheng Yu, Mei-Ying Li and Li-Sha Li |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Science and Technology Department Project of Jilin Province, China |
20230101163JC |
Outstanding Youth Fund Project of Jilin Provincial Department of Education, China |
JJKH20241324KJ |
|
Corresponding Author |
Li-Sha Li, PhD, Professor, The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, No. 126 Xinmin Street, Changchun 130021, Jilin Province, China. lilisha@jlu.edu.cn |
Key Words |
COVID-19; Cytokine storm; Immunomodulation; Mesenchymal stem cell; Mesenchymal stem cell-derived exosomes |
Core Tip |
As the coronavirus disease 2019 (COVID-19) pandemic normalizes, developing efficient treatments is critical to reducing the strain on the healthcare system. We summarize the various current treatments for COVID-19 and the mechanisms of damage caused by severe acute respiratory syndrome coronavirus 2. Through the comparison to existing treatments, we find that stem cell therapy has more research value. Mesenchymal stem cells (MSC) and their derived exosomes (MSC-Exo) have homing, immunomodulatory, and tissue repair abilities. They can reduce lung injury and inhibit pulmonary fibrosis. We summarized the clinical trials in recent years, analyzed the safety and effectiveness of MSC and MSC-Exo treatment from various aspects such as mechanism of action and therapeutic effect, and provided substantial theoretical support for their clinical application. |
Publish Date |
2024-04-25 05:24 |
Citation |
Hou XY, Danzeng LM, Wu YL, Ma QH, Yu Z, Li MY, Li LS. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19. World J Stem Cells 2024; 16(4): 353-374 |
URL |
https://www.wjgnet.com/1948-0210/full/v16/i4/353.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v16.i4.353 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345